Tier IIIBCL-2 inhibitor · senolytic
Navitoclax
BCL-2 inhibitor · senolytic
Recommended Dose
Trial-only
Purity Standard
99.0% — sourced from Trial only
Clinical Evidence
42 indexed trials · Tier III
Hallmarks Addressed
Hallmarks 08
BCL-2 inhibitor · senolytic
Trial-only
99.0% — sourced from Trial only
42 indexed trials · Tier III
Hallmarks 08